Low-dose IL-2 for Treg Expansion and Tolerance (LITE)

NCT02949492 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Safety concerns

Conditions

Transplantation
Liver Diseases

Interventions

DRUG: IL-2 (interleukin 2)

Sponsor

King's College London

Collaborators

[object Object]